What does the actual evidence say about microbiome treatments?
The honest answer is that the evidence is mixed and often underwhelming. For metabolic syndrome — a cluster of conditions like high blood pressure and blood sugar — fecal microbiome transplantation (FMT) has been tested as a way to shift the gut bacteria and improve health. But a 2023 review found that studies show 'mixed results regarding the effects on metabolic parameters as well as on the composition of the microbiome' [2]. That means sometimes FMT helps, sometimes it doesn't, and even when it does, scientists aren't sure exactly which bacterial changes caused the benefit.
Dietary interventions, often touted as a simple way to reshape your microbiome, also show limited effects. A 2020 review notes that even studies using fermentable fibers — which have clear effects on bowel function — 'revealed only very minor effects on overall microbiome composition and usually show only a very few species changing in population size' [4]. So while diet absolutely matters for health, its power to dramatically overhaul your gut bacteria in a targeted way is far smaller than many headlines suggest.
The core problem is that microbiome science is still young and faces major technical hurdles. A 2023 paper from multiple experts highlights that reproducibility and robustness are serious challenges, and that the field needs better research design, analysis, and control of confounding factors before its promise can be realized [1]. Another 2021 review puts it bluntly: microbiome research has been associated with 'over-hyped expectations that microbiome research will produce quick solutions to chronic and mechanistically complex human disorders' [5].
Who might actually benefit from microbiome therapies — and how much?
Right now, the most realistic benefits are in diagnosis and patient stratification — using a person's microbiome to predict disease risk or to group patients for more personalized treatment. A 2021 review notes that 'there is growing evidence that the microbiome could be utilized in medical diagnosis and patient stratification' [5]. This is a quieter but more achievable goal than curing complex diseases with a single probiotic pill.
For actual treatment, the picture is more cautious. There is 'clear evidence that microbiome modulation has the potential to influence metabolic diseases,' according to the 2023 review, but the same authors admit that 'it is not possible to distinguish which intervention is the most successful' [2]. That means a doctor today cannot confidently tell you which probiotic, prebiotic, or FMT will work for your specific condition. The potential is real, but the precision isn't there yet.
Even in more focused areas like the link between the esophageal microbiome and cancer, progress is slow. A 2021 review states that 'despite decades of work, we still have only a poor, low-resolution view of this community, which makes it hard to distinguish hope from hype' [3]. New techniques like culturomics and metagenomics may help, but they haven't delivered clinical tools yet.
So what should a typical person do with this information?
For now, the most evidence-backed step you can take is to eat a diverse, fiber-rich diet — not because it will magically transform your microbiome overnight, but because it supports overall health in ways that are well understood. The 2020 review emphasizes that diet is a key determinant of microbial populations, even if the effects are more subtle than often claimed [4]. Avoid expensive, unproven 'microbiome tests' or supplements that promise to fix your gut bacteria based on flimsy science.
Be skeptical of any product or protocol that claims to cure complex diseases like obesity, depression, or autoimmune disorders by 'balancing your microbiome.' The 2023 paper on robust microbiome science warns that the field is still working on basic reproducibility [1], and the 2021 review explicitly calls out 'over-hyped expectations' [5]. If something sounds too good to be true, it probably is — at least until larger, more rigorous trials prove otherwise.
The bottom line: microbiome science is a genuine frontier with real potential, but it is not ready for prime time as a treatment tool. Stay informed, but don't bet your health on it yet.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2020 to 2023, 2 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 42 papers retrieved from a database of over 500 million.
Sources used in this answer
From hype to hope: Considerations in conducting robust microbiome science
This 2023 review by multiple experts highlights that microbiome science faces serious challenges in reproducibility and robustness, and calls for better research design, analysis, and control of confounding factors before its promise can be realized.
Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
This 2023 review of microbiome modulation for metabolic syndrome finds that studies show mixed results for both metabolic parameters and microbiome composition, and concludes it is not yet possible to identify the most successful intervention.
The oesophageal microbiome and cancer: hope or hype?
This 2021 review of the esophageal microbiome and cancer states that after decades of work, scientists still have a poor, low-resolution view of this community, making it hard to distinguish hope from hype.
Diet and the gut microbiome: from hype to hypothesis.
This 2020 review of diet and the gut microbiome reports that dietary intervention studies, even with fermentable fibers, show only very minor effects on overall microbiome composition, with only a few species changing in population size.
Our Microbiome: On the Challenges, Promises, and Hype.
This 2021 review acknowledges that microbiome research has been associated with over-hyped expectations of quick solutions to complex disorders, while also noting realistic promise in diagnosis and patient stratification.